AMANDA DUNN: Open Payments
NPI 1568773935 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 10 payments from 7 companies in 2025. Trend: 2023 $199 · 2024 $427 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $60 |
| Optinose US, Inc. | 2 | $43 |
| GENZYME CORPORATION | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $20 |
Products named: DUPIXENT, DAXXIFY, Xhance, NUCALA, INSPIRE, STEALTHSTATION S8 PLATFORM.
Industry payments across UT — which companies pay providers there.
